Piomelli D, Greengard P
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, NY 10021.
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6770-4. doi: 10.1073/pnas.88.15.6770.
In preparations of synaptic terminals (synaptosomes) isolated from rat brain, the activity of phospholipase A2 (PLA2), a phospholipid hydrolase that serves a central function in signal transduction, was inhibited in a Ca(2+)-dependent manner by incubation with 60 mM K+ or with the Ca(2+)-selective ionophore ionomycin. Reversal by alkaline phosphatase treatment suggested that this inhibitory effect resulted from phosphorylation of a synaptosomal protein substrate. When lysed synaptosomes were incubated with Ca2+/calmodulin (CaM), purified Ca2+/CAM-dependent protein kinase II (Ca2+/CaM-dependent PK II) and ATP, PLA2 activity in lysates was nearly abolished within 10 min. This effect was accompanied by a marked decrease in the Vmax of the enzyme and little or no change in the Km. Furthermore, Ca2+/CaM with ATP but without exogenous Ca2+/CaM-dependent PK II partially inhibited PLA2 activity, and this effect was prevented by treating the lysates with a selective peptide inhibitor of Ca2+/CaM-dependent PK II. In contrast, incubation of intact synaptosomes with 4 beta-phorbol 12-myristate 13-acetate or of lysed synaptosomes with purified protein kinase C had little or no effect on PLA2 activity. The results strongly suggest that the Ca(2+)-dependent inhibition of PLA2 activity observed in intact nerve endings was produced by activation of the multifunctional Ca2+/CaM-dependent PK II. A membrane-permeable adenylyl cyclase activator, forskolin, enhanced PLA2 activity in intact synaptosomes, and cAMP-dependent protein kinase potentiated PLA2 activity in lysed synaptosomes. Furthermore, another broad-spectrum protein kinase present in synaptic terminals, casein kinase II, also potentiated PLA2 activity in lysed synaptosomes. The effects of both protein kinases were associated with a decrease in Km and no change in Vmax. The results suggest that PLA2 activity in synaptic terminals is subject to bidirectional control by distinct signal transduction pathways. Moreover, mutually antagonistic effects of the Ca2+/CaM-dependent PK II and PLA2 pathways provide a possible molecular mechanism for bidirectional modulation of neurotransmitter release.
在从大鼠脑部分离出的突触终末(突触体)制剂中,磷脂酶A2(PLA2,一种在信号转导中起核心作用的磷脂水解酶)的活性,通过与60 mM K+或与Ca(2+)选择性离子载体离子霉素孵育,以Ca(2+)依赖的方式受到抑制。碱性磷酸酶处理后的逆转表明,这种抑制作用是由突触体蛋白底物的磷酸化引起的。当裂解的突触体与Ca2+/钙调蛋白(CaM)、纯化的Ca2+/CaM依赖性蛋白激酶II(Ca2+/CaM依赖性PK II)和ATP一起孵育时,裂解物中的PLA2活性在10分钟内几乎完全丧失。这种效应伴随着该酶Vmax的显著降低,而Km几乎没有变化或没有变化。此外,Ca2+/CaM与ATP但没有外源性Ca2+/CaM依赖性PK II部分抑制了PLA2活性,并且通过用Ca2+/CaM依赖性PK II的选择性肽抑制剂处理裂解物来阻止这种效应。相反,用4β-佛波醇12-肉豆蔻酸酯13-乙酸酯孵育完整的突触体或用纯化的蛋白激酶C孵育裂解的突触体对PLA2活性几乎没有影响。结果强烈表明,在完整神经末梢中观察到的PLA2活性的Ca(2+)依赖性抑制是由多功能Ca2+/CaM依赖性PK II的激活产生的。一种膜通透性腺苷酸环化酶激活剂福斯高林增强了完整突触体中的PLA2活性,并且cAMP依赖性蛋白激酶增强了裂解突触体中的PLA2活性。此外,突触终末中存在的另一种广谱蛋白激酶酪蛋白激酶II也增强了裂解突触体中的PLA2活性。两种蛋白激酶的作用都与Km的降低和Vmax的不变有关。结果表明,突触终末中的PLA2活性受到不同信号转导途径的双向控制。此外,Ca2+/CaM依赖性PK II和PLA2途径的相互拮抗作用为神经递质释放的双向调节提供了一种可能的分子机制。